Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. UK/
    2. Our innovation /
    3. Focus areas /
    4. Neuroscience

    Neuroscience

    JJ_Neuroscience_Promo.jpg

    Our focus in neuroscience

    At Johnson & Johnson Innovative Medicine (J&J) UK, our goal is to enhance the quality of life for patients affected by nervous system disorders in the UK.

    We are dedicated to developing targeted and impactful treatment options that alleviate the burden of neurological conditions, supported by an evolving pipeline that strengthens our innovative products.

    Through our in-house discovery, strategic partnerships and acquisitions, we are transforming our approach to understanding and treating these complex conditions.

    Our legacy in neuroscience

    At J&J we are committed to advancing the field of neuroscience through continuous innovation and collaboration. Building on a legacy of over 70 years in neuroscience leadership, we are driving cutting-edge research in biomarkers, data science, and clinical trials to deepen our understanding of the underlying biology of neurological disorders.

    In the UK, we also aim to support the medical community through medical education, helping to ensure healthcare practitioners are equipped with the latest advancements to improve patient care.
    70
    Years of innovation in neuroscience
    100+
    UK medical education meetings to support healthcare practitioners with bringing the latest medical advancements to patients
    patient-centered-research-and-collaboration-portrait.png

    Patient-centered research and collaboration

    At J&J, we are inspired by the patients and caregivers we serve, placing them at the heart of everything we do. Health is personal, and we take neurological health personally.

    We understand the diversity of individuals affected by neurological and neuropsychiatric conditions, which is why we are committed to a tailored approach in our research and product development. Rather than relying on a “one-size-fits-all” model, we focus on addressing the unique needs of each patient, ensuring our therapies and support initiatives align with the real, unmet needs of those we aim to help.

    Our success in neuroscience is also deeply rooted in collaboration. By fostering strong partnerships with leading experts, healthcare bodies, and government organisations, we aim to accelerate access to care, eliminate barriers to diagnosis, and deliver practical, transformative solutions for patients in the UK and worldwide.

    Our vision in neuroscience

    At J&J, our focus is on understanding the biological causes of neurological disorders to develop more effective treatments. Our continued commitment to innovation aims to improve outcomes for those living with neurological conditions.
    16.5M
    People impacted in the UK1
    1 in 6
    People in the UK living with a neurological condition1
    With over 70 years of heritage in neuroscience, Johnson & Johnson continues to build on its deep scientific understanding to explore meaningful advances in neurodegenerative and autoimmune conditions. Our commitment to improving the lives of people affected by neurological disorders guides our ongoing research and collaborations.
    Amy Grey
    Business Unit Director, Immunology, PAH, Value Maximisers portfolio, and Cross-Opco functions
    jj-photo-lab-tech-inspecting-substance-in-bottle-im-1star.jpg
    How we work

    Partner with us

    We are committed to partnering with those whose innovative thinking will bring new and creative solutions to the field of medicine
    Reach out

    References
    1: The Neurological Alliance. Neuro Numbers 2019. March 2019. Available at: https://www.neural.org.uk/wp-content/uploads/2021/04/neuro-numbers-2019-1.pdf . Last accessed: November 2024.

    CP-486605 | October 2025